If you need more lookups,
subscriptions start at $34 USD/month.
Amanda Onuskanich Location
Stockton, NJ, US
Amanda Onuskanich Work
Senior Director, Clinical Program Management @ (September 2025 - Present)
Senior Director, Research and Development Program Management @ Marinus Pharma (January 2024 - September 2025)
Director of Research and Development Program Management @ Marinus Pharma (March 2022 - December 2023)
Associate Director of Chemistry, Manufacturing and Controls @ (November 2018 - March 2022)
Consultant and Digital Medicine Program Manager @ Pharmica Consulting Inc/ Otsuka US Digital Medicine Team (September 2017 - November 2018)
Associate Director, Non-Clinical Development @ merganser biotech (February 2016 - December 2016)
Clinical Manufacturing Manager, CMC @ (November 2012 - February 2016)
Analytical Systems Coordinator @ Emerson Resources (March 2012 - November 2012)
Analytical Chemist, MMD @ (September 2009 - March 2012)
Analytical Chemist @ (October 2006 - May 2009)
Amanda Onuskanich Education
The University of Charleston
Biochemistry
2001-2005
Amanda Onuskanich Skills
V&V
Change Control
Technology Transfer
Analytical Method Validation
Oncology
Protocol
Raw Materials
Dissolution Testing
Regulatory Affairs
GxP
ICH guidelines
Deviations
Regulatory Submissions
CRO
Analytical Method
Manufacturing
Marketing
Resources
Leadership
Chemistry
GMP
Amanda Onuskanich Summary
Amanda Onuskanich, based in Stockton, NJ, US, is currently a Senior Director, Clinical Program Management at Avalo Therapeutics. Amanda Onuskanich brings experience from previous roles at Marinus Pharma, Verrica Pharmaceuticals and Pharmica Consulting Inc/ Otsuka US Digital Medicine Team. Amanda Onuskanich holds a 2001 - 2005 Biochemistry @ The University of Charleston. With a robust skill set that includes V&V, Change Control, Technology Transfer, Analytical Method Validation, Oncology and more. Amanda Onuskanich has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Amanda Onuskanich?
Find contact details for 700 million professionals.